<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="199285">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00496171</url>
  </required_header>
  <id_info>
    <org_study_id>PC CE102/07</org_study_id>
    <nct_id>NCT00496171</nct_id>
  </id_info>
  <brief_title>Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers</brief_title>
  <official_title>A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Photocure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Photocure</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the most effective formulation of HAL for release
      of hexaminolevulinate to the cervical epithelium at different doses.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <condition>Healthy</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, pre-menopausal female volunteers

        Exclusion Criteria:

          -  Acute or chronic disease which could influence the study results
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claes G Trop√©, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Riks-Radium University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riks-Radium University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <lastchanged_date>January 15, 2009</lastchanged_date>
  <firstreceived_date>July 3, 2007</firstreceived_date>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
